Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 121

Results For "EY"

3284 News Found

Philips and World Stroke Organization partner to improve access to high-quality stroke care
News | October 11, 2023

Philips and World Stroke Organization partner to improve access to high-quality stroke care

Two-year partnership focused on advocacy, education, and raising awareness of stroke as a global healthcare challenge


Evonik introduces the world’s first carbon-fiber reinforced PEEK filament for 3D printed medical implants
News | October 11, 2023

Evonik introduces the world’s first carbon-fiber reinforced PEEK filament for 3D printed medical implants

Alignment of carbon-fiber can be controlled during the 3D printing process


Astellas, BioLabs and Mitsui Fudosan collaborate to enhance life science ecosystems in Tsukuba and Kashiwa-no-ha, Japan
News | October 11, 2023

Astellas, BioLabs and Mitsui Fudosan collaborate to enhance life science ecosystems in Tsukuba and Kashiwa-no-ha, Japan

Astellas stands on the forefront of healthcare change to turn innovative science into value for patients


American Oncology Institute launched Bone Marrow Transplant programs in India
Healthcare | October 09, 2023

American Oncology Institute launched Bone Marrow Transplant programs in India

Expanding to states like Maharashtra, Andhra Pradesh, Telangana, and Manipur while marking the significant milestone in its journey towards providing accessible healthcare services


Dozee unveils ‘Dozee Pro Ex’ for seamless continuum of monitoring from hospital to home
Digitisation | October 09, 2023

Dozee unveils ‘Dozee Pro Ex’ for seamless continuum of monitoring from hospital to home

Dozee Pro Ex will offer Ambulatory patient monitoring for a seamless continuum of patient monitoring across different care settings


Biocon signs commercialization agreement with Juno Pharmaceuticals in Canada
News | October 09, 2023

Biocon signs commercialization agreement with Juno Pharmaceuticals in Canada

Biocon will be responsible for obtaining regulatory approval for Liraglutide, and thereafter, for the manufacture and supply of the product in the Canadian market


Reclassify nicotine replacement therapies as prescription drugs, says Doctor
News | October 07, 2023

Reclassify nicotine replacement therapies as prescription drugs, says Doctor

NRT offers 50% higher success rate in quitting smoking compared to unassisted attempts


Apollo launches Hyderabad's first homecare recovery program
News | October 06, 2023

Apollo launches Hyderabad's first homecare recovery program

This integrated care offering is a step forward in our vision of providing an effective continuum of care for patients


Lonza further extends collaboration with major biopharmaceutical partner for manufacturing antibody-drug conjugates
News | October 06, 2023

Lonza further extends collaboration with major biopharmaceutical partner for manufacturing antibody-drug conjugates

The extension builds upon an existing long-term collaboration for end-to-end ADC manufacturing, including payload, monoclonal antibody (mAb) manufacturing and bioconjugation